Unpacking EssilorLuxottica’s Surprise $1.5 Billion Deal for Supreme

In This Article:

Updated July 17 at 4 p.m. ET

There’s something in Supreme that makes companies see themselves differently and makes them ready to try new things.

More from WWD

So it was with VF Corp. when it bought the exclusive and often elusive luxe street brand for $2.1 billion in 2020 — and so it is with EssilorLuxottica, which agreed on Wednesday to takeover the brand for $1.5 billion in cash.

“We see an incredible opportunity in bringing an iconic brand like Supreme into our company,” said Francesco Milleri, chairman and chief executive officer of EssilorLuxottica, in a statement with Paul du Saillant, deputy CEO.

That Supreme was being sold came as little surprise. The struggling VF admitted openly that it was looking to trim its portfolio — which also includes Vans, The North Face, Timberland and Dickies. And WWD reported in May that Supreme was quietly being shopped to potential buyers as Goldman Sachs helped VF review its assets.

The fact that the buyer was eyewear giant EssilorLuxottica did raise a few eyebrows, but Milleri and du Saillant said the deal fit right into their strategy.

“It perfectly aligns with our innovation and development journey, offering us a direct connection to new audiences, languages and creativity,” they said. “With its unique brand identity, fully direct commercial approach and customer experience — a model we will work to preserve — Supreme will have its own space within our house brand portfolio and complement our licensed portfolio as well. They will be well-positioned to leverage our group’s expertise, capabilities and operating platform.”

The Supreme/Emilio Pucci capsule collection dropping on June 10.
From the Supreme/Emilio Pucci capsule collection.

EssilorLuxottica also advanced its med-tech strategy on Wednesday with a deal to acquire an 80 percent stake in Heidelberg Engineering, a German company specializing in diagnostic solutions, digital surgical technologies and healthcare IT for clinical ophthalmology.

The multitasking gave EssilorLuxottica investors a lot to take in. Shares of the company fell 4.5 percent to 189.85 euros, leaving it with a still-massive market capitalization of 86.5 billion euros.

Jefferies’ James Grzinic said in a report, entitled “More Than Meets the Eye?,” that “investors’ underwhelming reaction” to the two acquisitions “likely reflects the market’s lukewarm assessment of Supreme’s prospects. And of how this fits within a group that had proactively sought to shift away from its historic consumer focus.

“What will make this a synergistic acquisition for EssilorLuxottica does not seem obvious to investors, judging by today’s price reaction. We presume that EL’s thinking is very much along the same lines of the historic purchase of Oakley.”